Reference 7b
Magnetic resonance imaging for staging cervical and endometrial cancer
Magnetic resonance imaging for staging cervical and endometrial cancer
Reference No. | 7b |
| Reference Name | Magnetic resonance imaging for staging cervical and endometrial cancer |
| Advisory Panels | Professor Brendon Kearney (Chair and MSAC member) Mr Stephen Blamey (MSAC member) Mr Alan Keith (MSAC member) Dr David Brazier (Royal Australian and New Zealand College of Radiologists nominee) Dr Graeme Dickie (Royal Australian and New Zealand College of Radiologists nominee) Dr Stacey Goergen (Royal Australian and New Zealand College of Radiologists nominee) Professor Bruce Ward (Royal Australian and New Zealand College of Gynaecologists and Obstetricians nominee) Mr Leo Pomery (Consumers' Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | 1 August 2000 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 13 November 2001 meeting. The MSAC recommends that on the strength of evidence pertaining to magnetic resonance imaging (MRI) for staging of cervical and endometrial cancer that: 1. Public funding should be supported for MRI staging of histolocially proven cervical cancer at FIGO stages IB or greater following assessment by examination under anaesthesia. 2. At present there is insufficient evidence to support public funding for the MRI in patients with recurrent cervical cancer but further studies may require this issue to be reviewed in the future. 3. Public funding should not be supported for MRI staging of endometrial cancer at this time. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing 5 February 2002 |
| Stage 5 - Implementation |  |
Page currency, Latest update: 30 March, 2009
